Pharmaceutical Quality (Industry), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/uv-dx-pq/ and changes regularly. See the Directory of published versions
Details about drug substance or drug product release and stability specification (tests, acceptance criteria).
MedicinalProductDefinition | The drug product (Stelbat tablets, 20mg) |
Ingredient | The active ingredient (stelbatalol) or the ingredients that make up the drug product |
SubstanceDefinition | Chemical or biological details about substance(s) associated with the ingredient |
PlanDefinition | Describes the specification set of tests |
ObservationDefinition | Each individual test and acceptance criteria; also used to group closely related tests |
Organization | (not illustrated above): The company/site that performed the testing or manufacturing |
CTD section synthetic source data samples (PDF):
XML and JSON examples of synthetic quality data:
HTML presentation example of synthetic quality data:
SubstanceDefinition | The substance which this is a specification for |
PlanDefinition | Describes the specification set of tests |
ObservationDefinition | Each individual test and acceptance criteria; also used to group closely related tests |
CTD section synthetic source data samples (PDF):
XML and JSON examples of synthetic quality data:
HTML presentation example of synthetic quality data: